Skip to main content
Toggle navigation
Login
Home
Back
Favorite
Like
Facebook
Tweet
Session 7: The Era of ADCs in the Treatment of NSCLC Part 1: Class Overview and Specifics of TROP2, HER3, c-MET, and CEACAM5 Investigational ADCs
Thursday, September 21, 2023
3:35 PM – 4:20 PM
ET
Presenter(s)
Barbara Melosky, MD
Bc Cancer
Slides
Slides